Predicting carbapenem-resistant Pseudomonas aeruginosa infection risk using XGBoost model and explainability

被引:0
作者
Jiang, Yan [1 ]
Wang, Hong-wei [2 ]
Tian, Fang-ying [3 ]
Guo, Yue [1 ]
Wang, Xiu-mei [1 ]
机构
[1] Shanxi Med Univ, Shanxi Bethune Hosp, Shanxi Acad Med Sci, Tongji Shanxi Hosp,Dept Nursing,Hosp 3, Taiyuan 030032, Peoples R China
[2] Shanxi Med Univ, Taiyuan 030000, Peoples R China
[3] Shanxi Med Univ, Dept Hosp Infect, Hosp 2, Taiyuan 030000, Peoples R China
关键词
Carbapenem resistance; Pseudomonas aeruginosa; Machine learning models; XGBoost; Risk factors; PNEUMONIAE; MORTALITY; IMPACT;
D O I
10.1038/s41598-025-04028-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The prevalence and spread of carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global public health problem. This study aims to identify the risk factors of CRPA infection and construct a machine learning model to provide a prediction tool for clinical prevention and control. A total of 1949 patients with P.aeruginosa health care-associated infections (HAIs) were enrolled in this study. A total of 89 patients with CRPA infection and 89 patients with CSPA infection were matched 1:1. LASSO regression was used to screen the variables, and the XGBoost model was established (136 cases in the training set and 60 cases in the test set). Shapley additive explain (SHAP) method was used to explain the importance of variables. The area under the ROC curve (AUC) and calibration curve were used to evaluate the performance of the model. There were 89 cases of CRPA infection, and the CRPA infection rate was 4.57%. Respiratory tract was the most common source of infection, and ICU and hematology department were the high-risk departments. The AUC value of the XGBoost machine learning model in the training set was 0.987 (95%CI: 0.974-1.000), and the AUC value in the test set was 0.862 (95%CI: 0.750-0.974). The clinical decision curve also showed good results of the model. SHAP results showed that ICU admission, duration of central venous catheterization, use of carbapenems and fluoroquinolones were important factors for predicting CRPA infection. The XGBoost machine learning model is helpful for the early prevention and screening of CRPA infection in medical institutions. Infection control and clinical departments should carry out effective prevention and control for high-risk factors to reduce the occurrence of CRPA infection.
引用
收藏
页数:11
相关论文
共 28 条
[1]  
[Anonymous], 2014, PERFORMANCE STANDARD, V24th
[2]   Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens [J].
Behzadi, Payam ;
Ambrosi, Cecilia ;
Scribano, Daniela ;
Zanetti, Stefania ;
Sarshar, Meysam ;
Gajdacs, Mario ;
Donadu, Matthew Gavino .
FRONTIERS IN MICROBIOLOGY, 2022, 13
[3]   Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis [J].
Britt, Nicholas S. ;
Ritchie, David J. ;
Kollef, Marin H. ;
Burnham, Carey-Ann D. ;
Durkin, Michael J. ;
Hampton, Nicholas B. ;
Micek, Scott T. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
[4]   Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study [J].
Coppry, M. ;
Jeanne-Leroyer, C. ;
Noize, P. ;
Dumartin, C. ;
Boyer, A. ;
Bertrand, X. ;
Dubois, V. ;
Rogues, A-M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (02) :503-510
[5]  
Hospital H., 2023, Variation in resistance of Pseudomonas aeruginosa to Imipenem and meropenem
[6]   Predicting 30-days mortality for MIMIC-III patients with sepsis-3: a machine learning approach using XGboost [J].
Hou, Nianzong ;
Li, Mingzhe ;
He, Lu ;
Xie, Bing ;
Wang, Lin ;
Zhang, Rumin ;
Yu, Yong ;
Sun, Xiaodong ;
Pan, Zhengsheng ;
Wang, Kai .
JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
[7]   A Systematic Review and Meta- Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for CarbapenemResistant Pseudomonas aeruginosa [J].
in 't Holt, Anne F. Voor ;
Severin, Juliette A. ;
Lesaffre, Emmanuel M. E. H. ;
Vos, Margreet C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (05) :2626-2637
[8]   Genomic epidemiology and molecular characteristics of blaNDM-1-positive carbapenem-resistant Pseudomonas aeruginosa belonging to international high-risk clone ST773 in the Gauteng region, South Africa [J].
Jung, Hyunsul ;
Pitout, Johann D. D. ;
Matsumura, Yasufumi ;
Strydom, Kathy-Anne ;
Kingsburgh, Chanel ;
Ehlers, Marthie M. ;
Kock, Marleen M. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (04) :627-640
[9]   Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital [J].
Kaier, Klaus ;
Heister, Thomas ;
Goetting, Tim ;
Wolkewitz, Martin ;
Mutters, Nico T. .
BMC INFECTIOUS DISEASES, 2019, 19 (01)
[10]   Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes [J].
Lautenbach, Ebbing ;
Weiner, Mark G. ;
Nachamkin, Irving ;
Bilker, Warren B. ;
Sheridan, Angela ;
Fishman, Neil O. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (09) :893-900